Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros

Métodos Terapéuticos y Terapias MTCI
Bases de datos
Tipo del documento
País de afiliación
Intervalo de año de publicación
1.
Poult Sci ; 88(11): 2315-23, 2009 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-19834081

RESUMEN

A dose titration and reduced duration medication study were performed to evaluate the current enrofloxacin treatment schedule in growing turkeys experimentally infected with avian metapneumovirus and Ornithobacterium rhinotracheale. Experimental groups of 17 four-week-old turkeys were first infected with avian metapneumovirus and 3 d later with O. rhinotracheale. Enrofloxacin treatment in the drinking water was started 24 h after O. rhinotracheale inoculation. In the dose titration study, enrofloxacin doses of 5, 10, and 20 mg/kg of BW were administered for 5 successive days. In the reduced duration medication study, the following enrofloxacin regimens were compared: 25 mg/kg of BW per day on d 0 and 2; 15 mg/kg of BW per day on d 0, 2, and 4; and 10 mg/kg of BW for 5 successive days. In both studies, all enrofloxacin treatments were equally efficacious (i.e., equally capable of shortening the course of clinical disease), eliminating O. rhinotracheale from the respiratory tract and reducing gross lesions. Ornithobacterium rhinotracheale bacteria were not recovered from any of the birds on enrofloxacin-supplemented media, indicating that none of the used treatment regimens promoted the selection of bacterial clones with reduced susceptibility or resistance to this antimicrobial agent. In conclusion, none of the alternative enrofloxacin treatment regimens yielded better results than the current prescribed treatment (i.e., 10 mg/kg of BW for 5 successive days) of O. rhinotracheale infections in turkeys. However, the reduced duration of application would offer a less time-consuming and equally effective alternative.


Asunto(s)
Infecciones por Flavobacteriaceae/veterinaria , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/farmacología , Infecciones por Paramyxoviridae/veterinaria , Enfermedades de las Aves de Corral/tratamiento farmacológico , Pavos , Animales , Antibacterianos/administración & dosificación , Antibacterianos/farmacología , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Enrofloxacina , Infecciones por Flavobacteriaceae/tratamiento farmacológico , Metapneumovirus , Ornithobacterium , Infecciones por Paramyxoviridae/tratamiento farmacológico
2.
Vet Microbiol ; 98(2): 165-8, 2004 Feb 04.
Artículo en Inglés | MEDLINE | ID: mdl-14741129

RESUMEN

Porcine circovirus type 2 (PCV2) is now recognised as the causal agent of porcine multisystemic wasting syndrome (PMWS), an economically important wasting disease of young pigs [J. Vet. Diagn. Invest. 12 (2000) 3]. Gross lesions of PMWS include generalised lymphadenopathy, hepatitis, nephritis and pneumonia and typical histological lesions include lymphocytic depletion and multinucleated giant cell formation in lymph nodes, degeneration and necrosis of hepatocytes, and multifocal lymphohistocytic interstitial pneumonia. This communication will review the results of experimental infections of gnotobiotic (GN), colostrum-deprived (CD) and colostrum-fed (CF) pigs within our group, and elsewhere, with PCV2 and the conclusions that can be drawn from this work.


Asunto(s)
Infecciones por Circoviridae/veterinaria , Circovirus/crecimiento & desarrollo , Infecciones por Parvoviridae/veterinaria , Parvovirus Porcino/crecimiento & desarrollo , Enfermedades de los Porcinos/virología , Síndrome Debilitante/veterinaria , Animales , Infecciones por Circoviridae/complicaciones , Infecciones por Circoviridae/inmunología , Infecciones por Circoviridae/virología , Circovirus/inmunología , Calostro/inmunología , Vida Libre de Gérmenes , Infecciones por Parvoviridae/complicaciones , Infecciones por Parvoviridae/inmunología , Infecciones por Parvoviridae/virología , Parvovirus Porcino/inmunología , Porcinos , Síndrome Debilitante/complicaciones , Síndrome Debilitante/inmunología , Síndrome Debilitante/virología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA